rewirebio.iobenchmarks
Dataset

So 2024 BRCA1 conflicting-classification missense cohort

450 BRCA1 missense variants with conflicting ClinVar interpretations as of 20 December 2022, drawn from 12,719 total BRCA1 ClinVar variants (654 conflicting).

Evaluation results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
58.9% Percent agreement
percent · higher

Uncertainty: 95% CI 52.0 to 66.4

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."
Configuration: VarSome vs. CanVIG-UK three-category concordance comparisonProtocol: So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
Dataset: So 2024 BRCA1 conflicting-classification missense cohort
265 Count (concordant classifications)
count · unknown

Uncertainty: Not applicable: reported at the rate level only; see concordance_rate result

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

So 2024 VarSome-vs-CanVIG-UK agreement evaluation

Not reported

Aggregation: Not reported

Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Results, Section 3.3, "Comparison of Classification Results Between Varsome and CanVIG-UK": "The overall concordance rate was 58.9% (95% CI: 52.0-66.4%; 265/450) between VarSome and CanVIG-UK (Figure 2)."

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-adc15377fab2 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

6 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Conflicting variant count
654
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.conflicting_variant_count

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Missense subset count
450
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.missense_subset_count

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
Materials and Methods, Section 2.1, "ClinVar Data Extraction"
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Total clinvar brca1 variant count
12719
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.total_clinvar_brca1_variant_count

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
450 BRCA1 missense variants with conflicting ClinVar interpretations as of 20 December 2022, drawn from 12,719 total BRCA1 ClinVar variants (654 conflicting).
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
So 2024 BRCA1 conflicting-classification missense cohort
Context-only references
Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance

Original source ↗

Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Retrieved: 2026-10-05T14:02:27Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 1c38f665dab61743881dcb40302e0e5e0583aa72e106c95a3939a21d6213beda

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20261005-so-2024-cohort.

Source locator: Materials and Methods, Section 2.1, "ClinVar Data Extraction"

Related records

Suggest a correction